Adagene Statistics
Total Valuation
Adagene has a market cap or net worth of $104.16 million. The enterprise value is $49.60 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Adagene has 47.13 million shares outstanding. The number of shares has increased by 5.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 47.13M |
| Shares Change (YoY) | +5.61% |
| Shares Change (QoQ) | +2.67% |
| Owned by Insiders (%) | 8.20% |
| Owned by Institutions (%) | 10.35% |
| Float | 12.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,022.96 |
| Forward PS | n/a |
| PB Ratio | 2.66 |
| P/TBV Ratio | 2.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 480.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.29 |
| Quick Ratio | 2.20 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.90 |
Financial Efficiency
Return on equity (ROE) is -63.26% and return on invested capital (ROIC) is -34.10%.
| Return on Equity (ROE) | -63.26% |
| Return on Assets (ROA) | -24.89% |
| Return on Invested Capital (ROIC) | -34.10% |
| Return on Capital Employed (ROCE) | -87.68% |
| Revenue Per Employee | $748 |
| Profits Per Employee | -$216,592 |
| Employee Count | 138 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -18,483 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.68% in the last 52 weeks. The beta is 0.74, so Adagene's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -21.68% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 1.90 |
| Relative Strength Index (RSI) | 54.82 |
| Average Volume (20 Days) | 108,111 |
Short Selling Information
| Short Interest | 16,835 |
| Short Previous Month | 57,127 |
| Short % of Shares Out | 0.04% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, Adagene had revenue of $103,204 and -$29.89 million in losses. Loss per share was -$0.64.
| Revenue | 103,204 |
| Gross Profit | 103,204 |
| Operating Income | -33.32M |
| Pretax Income | -32.47M |
| Net Income | -29.89M |
| EBITDA | -32.77M |
| EBIT | -33.32M |
| Loss Per Share | -$0.64 |
Full Income StatementBalance Sheet
The company has $62.83 million in cash and $6.85 million in debt, giving a net cash position of $55.98 million or $1.19 per share.
| Cash & Cash Equivalents | 62.83M |
| Total Debt | 6.85M |
| Net Cash | 55.98M |
| Net Cash Per Share | $1.19 |
| Equity (Book Value) | 37.91M |
| Book Value Per Share | 0.80 |
| Working Capital | 36.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$27.46 million and capital expenditures -$23,528, giving a free cash flow of -$27.48 million.
| Operating Cash Flow | -27.46M |
| Capital Expenditures | -23,528 |
| Free Cash Flow | -27.48M |
| FCF Per Share | -$0.58 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -32,283.60% |
| Pretax Margin | -28,979.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Adagene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.61% |
| Shareholder Yield | -5.61% |
| Earnings Yield | -28.31% |
| FCF Yield | -26.03% |
Analyst Forecast
The average price target for Adagene is $7.00, which is 216.74% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 216.74% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 296.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Adagene has an Altman Z-Score of -5.79 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.79 |
| Piotroski F-Score | 1 |
